Product image of Levonoraristo (Levonorgestrel) supplied by GNH India

Levonoraristo

Active Ingredient:
Levonorgestrel
Origin:
EU

Levonoraristo (Levonorgestrel)

Levonorgestrel, the active ingredient in Levonoraristo, is a progestogen presented as an oral tablet for systemic use. It is employed to prevent pregnancy, including emergency contraception after unprotected intercourse, and as a regular contraceptive method for women of reproductive age.

GNH India supplies Levonoraristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Its global distribution network ensures timely delivery and compliance with local regulatory requirements.

Manufacturer / TM Owner

Aristo Pharma Gmbh (Art 57)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levonorgestrel is a progestogen used in reproductive health to prevent pregnancy.

  • Emergency contraception: provides a high dose to inhibit ovulation and prevent implantation when taken within 72‑120 hours after unprotected intercourse.
  • Regular contraceptive use: taken on a scheduled basis to suppress ovulation and maintain contraceptive protection for women seeking ongoing birth control.
  • Prevention of pregnancy after contraceptive failure: used as a backup method when a primary contraceptive method fails or is missed, reducing the risk of unintended pregnancy.

How It Works

  • Levonorgestrel binds to progesterone receptors in the hypothalamus and pituitary, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. It also thickens cervical mucus, creating a barrier to sperm penetration, and induces changes in the endometrial lining that reduce the likelihood of implantation should fertilization occur.

Side Effects

Levonorgestrel is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient cranial discomfort.
  • Breast tenderness: temporary sensitivity or swelling.
  • Irregular bleeding: spotting or changes in menstrual flow.
  • Abdominal pain: mild cramping or discomfort.
  • Fatigue: feeling unusually tired.

Serious or Rare Side Effects

  • Thromboembolic events: blood clot formation in veins or arteries.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Liver dysfunction: abnormal liver enzyme levels or hepatitis.
  • Pregnancy despite use: if implantation has already occurred.
  • Ectopic pregnancy: implantation outside the uterus, requiring urgent care.

Precautions & Warnings

Before using Levonoraristo, consider the following safety measures.

  • Timing of administration: take as soon as possible after unprotected intercourse for maximum effectiveness.
  • Hypersensitivity: avoid if you have a known allergy to levonorgestrel or any excipients.
  • Enzyme‑inducing drugs: concurrent use of strong inducers may lower efficacy; consult a healthcare professional.
  • Routine contraception: do not replace regular contraceptive methods without medical advice.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Levonorgestrel may interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Rifampin and other strong enzyme inducers: can markedly reduce contraceptive effectiveness.
  • Anticonvulsants such as phenytoin or carbamazepine: may lower plasma levonorgestrel levels.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): may increase levonorgestrel concentrations.
  • St. John’s wort: a herbal inducer that can diminish effectiveness.
  • Combined hormonal therapies: may produce additive hormonal effects; monitor for side‑effects.

Frequently Asked Questions

Levonoraristo contains levonorgestrel, a progestogen used to prevent pregnancy. It is indicated for emergency contraception after unprotected sex and as a regular oral contraceptive for women seeking ongoing birth control.

Levonorgestrel binds to progesterone receptors, suppressing the luteinizing hormone surge and preventing ovulation. It also thickens cervical mucus and alters the endometrial lining, creating conditions that reduce the chance of fertilization and implantation.

The specific dose and regimen of Levonoraristo are determined by a qualified prescriber based on the intended use, timing of administration, and individual patient factors. Patients should follow the healthcare professional’s instructions.

Levonoraristo is intended to prevent pregnancy and is not used during an established pregnancy. Its safety during breastfeeding has not been fully established; women should discuss any concerns with their healthcare provider before use.

To order Levonoraristo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levonoraristo’s active ingredient, levonorgestrel, is a widely used progestogen for emergency contraception. Compared with copper IUD insertion, it is less invasive but must be taken within a specific time window. Compared with ulipristal acetate, levonorgestrel is generally less effective after 72 hours but is more widely available.

Store Levonoraristo at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and efficacy.

Levonoraristo is taken orally, usually as a single tablet. For emergency use, it should be swallowed with water as soon as possible after unprotected intercourse, ideally within 72 hours, but it remains effective up to 120 hours depending on the regimen prescribed.

Serious risks, though rare, include thromboembolic events such as deep‑vein thrombosis, severe allergic reactions (anaphylaxis), and liver dysfunction. If any signs of these conditions appear, seek immediate medical attention.

Levonoraristo should be avoided by individuals with known hypersensitivity to levonorgestrel or any tablet excipients, those currently pregnant, or women with a history of thromboembolic disorders, severe liver disease, or uncontrolled hypertension unless advised otherwise by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.